Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara B Mettelman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pediatrics|March 3, 2005
Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung diseaseSteven J Gross, Ran D Anbar, Barbara B Mettelman
Journal of Developmental and Behavioral Pediatrics : JDBP|November 6, 2014
Predictive validity of the Bayley, Third Edition at 2 years for intelligence quotient at 4 years in preterm infantsMichelle M Bode, Diane B DʼEugenio, Barbara B Mettelman, et al.
The Journal of Pediatrics|July 28, 2019
Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm InfantsBonnie L Marr, Barbara B Mettelman, Michelle M Bode, et al.
The Journal of Pediatrics|March 2, 2020
ReplyBonnie L Marr, Barbara B Mettelman, Michelle M Bode, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pediatrics|March 3, 2005
Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung diseaseSteven J Gross, Ran D Anbar, Barbara B Mettelman
Journal of Developmental and Behavioral Pediatrics : JDBP|November 6, 2014
Predictive validity of the Bayley, Third Edition at 2 years for intelligence quotient at 4 years in preterm infantsMichelle M Bode, Diane B DʼEugenio, Barbara B Mettelman, et al.
The Journal of Pediatrics|July 28, 2019
Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm InfantsBonnie L Marr, Barbara B Mettelman, Michelle M Bode, et al.
The Journal of Pediatrics|March 2, 2020
ReplyBonnie L Marr, Barbara B Mettelman, Michelle M Bode, et al.
Pageof 1